GlassScriptPhysician profile
Zafrulla Khan
NPI 1982672150
$1,225.32
in general payments reported to CMS, 2019-2025
8 companies · $604 in 2025
The $604 reported for 2025 was more than what 76% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2022: $237 · 2023: $125 · 2024: $144 · 2025: $604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $873.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $286.67 | 2025 | Tepezza |
| Bayer Healthcare Pharmaceuticals INC. | $249.74 | 2022-2023 | |
| Gt Medical Technologies, INC | $171.96 | 2025 | Gammatile |
| Abiomed | $145.77 | 2025 | |
| Merck Sharp & Dohme LLC | $114.83 | 2019 | |
| Abbvie INC. | $112.39 | 2022 | |
| Medtronic, INC. | $82.20 | 2024 | Azure Xt Dr Mri Surescan |
| Keystone Dental INC. | $61.76 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zafrulla Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.